25
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.316
Exchange
XHKG - Hong Kong Exchange
-0.28 B
Last period CFO ,CNY
-140%
CFO has decreased in 3 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Venus Medtech
Company Analysis
2500.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2500.HK financial analysis by Eyestock methodology
Valuation
2500.HK valuation using historical relative method
Statements
2500.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2500.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Venus Medtech`s CFO for the period ended 2023-12-31 is -0.28 B CNY
